DAILYZ HEALTH NEWS

June 16, 2026 Evan Vega

Global obesity surge driving premature heart disease with peak rates now in people in their early 50s and fastest growth in South Asia, major ENDO 2026 study reports

A major study at ENDO 2026 finds global heart disease now peaks at ages 50-54, driven by rising obesity and fastest growth in South Asia.

$Semaglutide lowers fracture risk$

Health

June 16, 2026 Evan Vega

GLP-1 diabetes and obesity drugs like semaglutide tied to 15% lower fracture risk and potential bone health benefits versus other weight-loss medications

GLP-1 drugs like semaglutide linked to 15% lower fracture risk and greater weight loss in type 2 diabetes patients versus other obesity medications.

Health

June 16, 2026 Evan Vega

Long daytime naps over 30 minutes linked to higher risk of fatty liver disease in people with type 2 diabetes, new ENDO 2026 data suggest

A study at ENDO 2026 found that type 2 diabetes patients who nap over 30 minutes have a higher risk of fatty liver disease.

Health

June 15, 2026 Evan Vega

Bangladesh measles outbreak death toll surpasses 650 children as WHO and UNICEF rush emergency vaccination support to curb regional spread

Bangladesh’s measles outbreak has killed over 650 children, prompting WHO and UNICEF to launch emergency vaccinations for young children.

Health

June 14, 2026 Evan Vega

FDA clears first gene-edited cell therapy for severe sickle cell disease, paving way for wider use of CRISPR-based treatments in US hospitals

The FDA approved CASGEVY™, the first CRISPR gene-edited cell therapy, for severe sickle cell disease patients 12 and older with recurrent crises.

Global Drug-Resistant Tuberculosis Emergency

Health

June 5, 2026 Evan Vega

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Health

June 4, 2026 Evan Vega

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

The Biden administration announced a plan to cap insulin out-of-pocket costs at $35 monthly for all insured Americans, expanding beyond Medicare.

Health

June 3, 2026 Evan Vega

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

As of mid-2026, the FDA has not approved any gene-editing therapies for type 1 diabetes, with such treatments still in preclinical stages.

Health

June 2, 2026 Evan Vega

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

A six-month trial in NEJM found hybrid closed-loop insulin pumps improved A1c and reduced severe hypoglycemia in type 1 diabetes patients.

Health

June 2, 2026 Evan Vega

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

The FDA has not approved RebiQuent for moderate to severe atopic dermatitis; current oral treatments include abrocitinib and upadacitinib.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

Wyoming Department of Health Confirms Third Measles Case of 2026 in Unvaccinated Adult

FDA Approves Isatuximab On-Body Injector for Multiple Myeloma, Raising Anti-CD38 Competition

Healthcare ransomware attacks remain resilient in H1 2026 as extortion groups broaden supply chain attacks

IKS Health acquires TruBridge in $557 million deal

Lupin Pharmaceuticals recalls 2.5 million bottles of prescription steroid eye drops over contamination

Wyoming Department of Health Confirms Third Measles Case of 2026 in Unvaccinated Adult

FDA Approves Isatuximab On-Body Injector for Multiple Myeloma, Raising Anti-CD38 Competition

Healthcare ransomware attacks remain resilient in H1 2026 as extortion groups broaden supply chain attacks

IKS Health acquires TruBridge in $557 million deal

Wyoming Department of Health Confirms Third Measles Case of 2026 in Unvaccinated Adult

FDA Approves Isatuximab On-Body Injector for Multiple Myeloma, Raising Anti-CD38 Competition

Healthcare ransomware attacks remain resilient in H1 2026 as extortion groups broaden supply chain attacks

IKS Health acquires TruBridge in $557 million deal

Lupin Pharmaceuticals recalls 2.5 million bottles of prescription steroid eye drops over contamination

Wyoming Department of Health Confirms Third Measles Case of 2026 in Unvaccinated Adult

FDA Approves Isatuximab On-Body Injector for Multiple Myeloma, Raising Anti-CD38 Competition

Healthcare ransomware attacks remain resilient in H1 2026 as extortion groups broaden supply chain attacks

IKS Health acquires TruBridge in $557 million deal

Wyoming Department of Health Confirms Third Measles Case of 2026 in Unvaccinated Adult

FDA Approves Isatuximab On-Body Injector for Multiple Myeloma, Raising Anti-CD38 Competition

Healthcare ransomware attacks remain resilient in H1 2026 as extortion groups broaden supply chain attacks

IKS Health acquires TruBridge in $557 million deal

Lupin Pharmaceuticals recalls 2.5 million bottles of prescription steroid eye drops over contamination

Global obesity surge driving premature heart disease with peak rates now in people in their early 50s and fastest growth in South Asia, major ENDO 2026 study reports

GLP-1 diabetes and obesity drugs like semaglutide tied to 15% lower fracture risk and potential bone health benefits versus other weight-loss medications

Long daytime naps over 30 minutes linked to higher risk of fatty liver disease in people with type 2 diabetes, new ENDO 2026 data suggest

Bangladesh measles outbreak death toll surpasses 650 children as WHO and UNICEF rush emergency vaccination support to curb regional spread

FDA clears first gene-edited cell therapy for severe sickle cell disease, paving way for wider use of CRISPR-based treatments in US hospitals

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults